Recent Finacing
Recent Raise
Scribe Therapeutics is a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies to develop genetic medicines for cardiometabolic diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
